Is DXM legal in Japan?

Also known as: robo, dextromethorphan

Legal status

DXM is not a controlled substance in Japan, and the reason is an express exclusion rather than a silence. The narcotics table names its racemic and laevo relatives at 別表第一第七十一号, 「三―メトキシ―Ｎ―メチルモルヒナン（右旋性のものを除く。）及びその塩類」, 3-methoxy-N-methylmorphinan except the dextrorotatory form, and dextromethorphan is exactly that dextrorotatory form, so the entry carves it out. Levomethorphan and racemethorphan are narcotics under the same entry. Dextromethorphan is not named in the psychotropics, stimulants or designated substances lists either. Search record for this cell, run mechanically over the control lists (the e-Gov text of the narcotics Act, its Cabinet Order, enforcement order and rules, the Stimulants Control Act and its raw material order, the designated substances ordinance, the あへん法, the cultivation Act and the 麻薬特例法, and the MHLW and Narcotics Control Department list PDFs) on 2 October 2026: デキストロメトルファン, dextromethorphan. None of those terms appears anywhere in them. Japan has no analogue statute. The only structural catch-alls in force are the designated substances ordinance's 第三百六十号 and 第三百六十一号 (naphthoylindole synthetic cannabinoids), 第三百六十二号 (cathinones built on 2-amino-1-phenylpropan-1-one), 第三百六十三号 to 第三百六十五号 (dibenzopyran cannabinoids with a 3 to 8 carbon side chain) and the deemed narcotics of 麻薬及び向精神薬取締法第二条第二項, which the Cabinet Order's 第六条 confines to two tetrahydrocannabinolic acids. Tables searched, each as at its own status date: the MHLW designation tables, narcotics tables status 6 September 2026 (麻薬の指定状況 令和８年９月６日現在: the Act's 別表第一 with 76 substances and the Cabinet Order's 第一条 with 171, counts that match the e-Gov text read on 2 October 2026); the MHLW designation tables, psychotropics tables status 3 October 2025 (向精神薬の指定状況 令和７年10月３日現在: the Act's 別表第三 with 10 substances and the Cabinet Order's 第四条 with 80, counts that match the e-Gov text read on 2 October 2026); the MHLW designated substances list status 6 September 2026 (the English list headed as of September 6, 2026, 2,484 substances; the Japanese index dates its own copy 令和８年８月27日現在 and gives the same total); and, as at 2 October 2026 on e-Gov, the 覚醒剤取締法 第二条 and its 別表 with the stimulant raw material Cabinet Order (平成八年政令第二十三号), the あへん法 and the 大麻草の栽培の規制に関する法律. Each of those lists can move by Cabinet Order or ministerial ordinance without an Act of the Diet, and the narcotics and designated substances lists moved as recently as 6 September 2026, so this absence is stated as at those dates and does not rule out a later amendment.

Consequences if caught

Capital exposure: none. No Japanese drug statute provides a death sentence: 死刑 appears in the main provisions of none of the 麻薬及び向精神薬取締法 (the Narcotics and Psychotropics Control Act), the 覚醒剤取締法 (the Stimulants Control Act), the あへん法 (the Opium Act), the 大麻草の栽培の規制に関する法律 (the Cannabis Plant Cultivation Act), the pharmaceuticals Act (the PMD Act) or the 麻薬特例法 (the Narcotics Special Provisions Act), each read on e-Gov on 2 October 2026. Japan has not abolished capital punishment: 刑法第九条 lists it among the principal punishments, 「死刑、拘禁刑、罰金、拘留及び科料を主刑とし、没収を付加刑とする。」, and 第百九十九条 provides it for murder. No drug offence attaches to DXM as a substance, because it is outside every controlled lane listed under legal_status. What can attach is the pharmaceuticals Act's control of medicines: supplying an unapproved 医薬品 breaches 第五十五条第二項 or 第二十四条第一項 (the provisions the MHLW drug abuse page cites against unapproved products), and 第八十四条 punishes those breaches with up to three years or a fine of up to three million yen or both. Personal possession of a medicine is not one of those offences. A racemic methorphan product would not be DXM and would be a narcotic under 別表第一第七十一号.

If prescribed or medical

DXM has no controlled drug prescription rule in Japan because it is in no controlled lane. Whether a particular product is a prescription medicine there is a pharmaceuticals Act question about that product, not a drug control question, and this cell does not answer it for any brand.

Documentation

A foreign prescription does not make DXM importable by itself, but dextromethorphan is excluded from the narcotics table by name and is in no other controlled lane. The MHLW personal import guidance lets a traveller bring «Poison, Deadly poison, Prescription drug: Up to 1 month supply» without an Import Confirmation (輸入確認証), and needs that confirmation, obtained before departure, for anything more; it adds «Regardless of the description above, you cannot bring prohibited drugs and controlled drugs into Japan.» A foreign prescription does not itself make a medicine importable: it is the personal import rule, and nothing in the narcotics statutes, that governs this item. Tables relied on for the absence: narcotics tables status 6 September 2026, psychotropics tables status 3 October 2025 and designated substances list status 6 September 2026.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Japan’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.